Navigation Links
T-cell therapy eradicates an aggressive leukemia in 2 children
Date:3/25/2013

Two children with an aggressive form of childhood leukemia had a complete remission of their diseaseshowing no evidence of cancer cells in their bodiesafter treatment with a novel cell therapy that reprogrammed their immune cells to rapidly multiply and destroy leukemia cells. A research team from The Children's Hospital of Philadelphia and the University of Pennsylvania published the case report of two pediatric patients Online First today in The New England Journal of Medicine. It will appear in the April 18 print issue.

One of the patients, 7-year-old Emily Whitehead, was featured in news stories in December 2012 after the experimental therapy led to her dramatic recovery after she relapsed following conventional treatment. Emily remains healthy and cancer-free, 11 months after receiving bioengineered T cells that zeroed in on a target found in this type of leukemia, called acute lymphoblastic leukemia (ALL).

The other patient, a 10-year-old girl, who also had a complete response to the same treatment, suffered a relapse two months later when other leukemia cells appeared that did not harbor the specific cell receptor targeted by the therapy.

"This study describes how these cells have a potent anticancer effect in children," said co-first author Stephan A. Grupp, M.D., Ph.D., of The Children's Hospital of Philadelphia, where both patients were treated in this clinical trial. "However, we also learned that in some patients with ALL, we will need to further modify the treatment to target other molecules on the surface of leukemia cells."

Grupp is the director of Translational Research for the Center for Childhood Cancer Research at The Children's Hospital of Philadelphia, and a professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Michael Kalos, Ph.D., an adjunct associate professor in the department of Pathology and Laboratory Medicine in the Perelman School of Medicine at Pen
'/>"/>

Contact: Rachel Salis-Silverman
Salis@email.chop.edu
267-426-6063
Children's Hospital of Philadelphia

Holly Auer
holly.auer@uphs.upenn.edu
215-200-2313
Perelman School of Medicine, University of Pennsylvania


Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Infusion of stem cells and specially generated T-cells from same donor improves leukemia survival
2. Denosumab reduces burden of giant-cell tumor of the bone
3. Mayo Clinic completes first genome-wide analysis of peripheral T-cell lymphomas
4. UCLA, Caltech research on immune-cell therapy could strengthen promising melanoma treatment
5. Physical therapy as effective as surgery for torn meniscus and arthritis of the knee
6. PREFERRED Therapy Providers Selects WebOutcomes to Deliver Web-Based Outcomes for Their National Provider Network
7. Gene Therapy for Human Disease: Clinical Advances and Challenges
8. Immune Therapy Shows Early Promise for Advanced Leukemia
9. Dennis R. Hill MD Announces Launch of High Dose Rate Brachytherapy of Prostate Cancer Website
10. Therapy as Good as Surgery for Some With Torn Knee Cartilage
11. Women's Excellence in Pelvic Floor Physical Therapy Near Pontiac, MI, Now Offers Therapy After Vaginal Delivery to Prevent Urinary Incontinence, Improve Sexual Function
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... ... July 02, 2015 , ... Breakthrough technologies are now ... Dr. Lev Kalika, founder of New York Dynamic Neuromuscular Rehabilitation & Physical ... conservative treatment of back, hip, knee and shoulder pain as well as sports ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... (CVR) recently received nearly $4 million through five federal grants to study a ... therapies against the deadly diseases. , The research will be conducted in ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital ... new release of their flagship product, 3D Tooth Atlas, version 7.6. This release ... and new tutorial videos. This latest release of the 3D Tooth Atlas offers ...
(Date:7/2/2015)... ... July 02, 2015 , ... B. E. ... been retained to lead a national chief executive officer recruitment for ... in the healthcare industry, B. E. Smith has recently placed more than 1,000 ...
(Date:7/2/2015)... ... July 02, 2015 , ... After conducting a nationwide executive search ... Center in Yuma, Ariz., has hired Robert Trenschel, DO, as chief executive officer. ... Dr. Trenschel will assume his new duties at Yuma Regional Medical Center on July ...
Breaking Medicine News(10 mins):Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 2Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 3Health News:Breakthrough Technologies for Carpal Tunnel Treatment in New York City 4Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 2Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 3Health News:Mosquito-Borne Viruses Subject of $4M in Federal Grants to Scientists in Pitt’s Center for Vaccine Research 4Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 2Health News:Indiana Blood Center Retains B. E. Smith to Recruit New Chief Executive Officer 3Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 2Health News:Yuma Regional Medical Center Hires New Chief Executive Officer 3
... Mary Dean, president and CCO of,KickSkirt, Inc., will ... help moms,improve the health of their children while ... M2Moms(TM) - The Marketing-To-Moms Conference,October 23-24, 2007, Chicago ... MD, founder and medical director of Peak Wellness ...
... Finds Minnesota,s Seniors Face Fourth Highest Shortfall,Nationally; ... Oct. 4 A new independent,analysis of the ... estimates states are under funding the actual cost ... least $4.4 billion,annually -- representing a dramatic 45 ...
... approvals are being recorded, but backlog continues to grow, ... -- Despite improved handling of generic drug applications and ... a rising tide of requests for approvals, officials said ... 682 generic drugs, an increase of 33 percent from ...
... from the,University of Wisconsin comparing optical colonoscopy to ... Medicine today raises several,important issues for the public ... the abdomen. "Gastrointestinal physicians are committed to,preventing colorectal ... all of us on the front lines of ...
... October 4, 2007 A group working at the ... with the University of Pavia has discovered that telomeres, ... that progressively shorten every time a cell divides, also ... Science Express, calls into question our understanding of how ...
... WASHINGTON, Oct. 4 In a departure from,current ... encouraged,pregnant women and women of childbearing age to ... mercury, a highly potent,neurotoxin and other contaminants commonly ... pregnant women to eat more fish without,mentioning the ...
Cached Medicine News:Health News:Brands Tackle the Childhood Obesity Issue During M2Moms(TM) - The Marketing-To-Moms Conference 2Health News:New National Medicaid Study: Minnesota Under Funds Seniors' Nursing Home Care $167 Million Annually 2Health News:New National Medicaid Study: Minnesota Under Funds Seniors' Nursing Home Care $167 Million Annually 3Health News:FDA Struggles to Keep Pace With Requests for Generics 2Health News:FDA Struggles to Keep Pace With Requests for Generics 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 2Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 3Health News:Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities 4Health News:New telomere discovery could help explain why cancer cells never stop dividing 2
(Date:7/2/2015)... , July 2, 2015  New product launches are ... leading role in educating thought leaders about new products, ... heavily influence how well a new therapy performs at ... from research and consulting leader Best Practices, LLC, critical ... to focus on are early stage thought leader (TL) ...
(Date:7/2/2015)... July 2, 2015 Releases of ... Aedes aegypti , , reduced the dengue ... Brazil by 95%, well below the modelled ... http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal PLOS Neglected Tropical ... Oxitec,s genetically engineered mosquitoes. The results showed that in ...
(Date:7/2/2015)... Research and Markets( http://www.researchandmarkets.com/research/n7kzjb/vitamin_d_market ) ... by Analog, Application, End-User & by Region - Global Trends ... This market is projected to reach about $2.5 Million ... applications and rising opportunities in countries such as ... Italy , and Brazil . In ...
Breaking Medicine Technology:Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 2Vitamin D Market by Analog, Application, End-User & by Region - Global Trends & Forecast to 2020: Increasing Recommendation By Doctors & Associations 3
... Inc. (Nasdaq: PCYC ), announced today ... with Janssen Biotech, Inc., one of the Janssen ... to develop and commercialize PCI-32765, a novel, oral, ... for the treatment of Non Hodgkin,s Lymphoma, Chronic ...
... LLC , an established CRO providing clinical research services in ... biopharmaceutical industry, announced today that it is being featured in ... Terry Bradshaw.  According to the episode, it ... to launch a new drug, and even then, only one ...
Cached Medicine Technology:Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 2Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 3Pharmacyclics Forms Pact to Develop and Commercialize PCI-32765 for Hematologic Cancers with Janssen Biotech, Inc. 4ClinStar to Be Featured on Business Day TV With Terry Bradshaw 2
... has been developed specifically to fight Cellulite ... and hips. It does this by stimulating ... fluids in your body, which then are ... daily, for about 15 minutes each treatment. ...
A device combining the "palpate & roll technique to vacuum massage, innovation dedicated to efficiency....
... Midmarks 604 Manual ExamTable was ... patient in mind and gives you ... available. However, this cost-effective table does ... the new 604, the physician can ...
... The Midmark 622 and 623 High-Low Examination ... ,patients, staff and you. Many different types ... a ,physicians office how to get on the ... an exam table ,can increase a patients comfort ...
Medicine Products: